Parkinson's disease Archives -

Lilly pays up to $1.04bn for neurology gene therapy biotech Prevail

https://pharmaphorum.com/news/lilly-buys-neurology-gene-therapy-biotech-prevail/

Eisai forges CNS alliance with UK’s Wren Therapeutics

https://pharmaphorum.com/news/eisai-forges-cns-alliance-with-uks-wren-therapeutics/

Axovant pushes on with Parkinson’s gene therapy, despite investor cynicism

https://pharmaphorum.com/news/axovant-pushes-on-with-parkinsons-gene-therapy/

Bayer boosts cell therapy pipeline with BlueRock acquisition

https://pharmaphorum.com/news/bayer-boosts-cell-therapy-pipeline-with-bluerock-acquisition/

Abbott upgrades brain implant software

https://pharmaphorum.com/news/abbott-upgrades-brain-implants-software/

Sunovion’s Parkinson’s disease drug is a step closer to approval

https://pharmaphorum.com/news/sunovions-parkinsons-disease-drug-step-closer-approval/

e-Therapeutics and C4XD research Parkinson’s drugs

https://pharmaphorum.com/news/e-therapeutics-and-c4xd-research-parkinsons-drugs/

FDA probes Parkinson’s drug safety, Acadia’s shares collapse

https://pharmaphorum.com/news/fda-probes-parkinsons-drug-safety-acadias-shares-collapse/

Acadia shares hit by media doubts over Parkinson’s drug

https://pharmaphorum.com/news/acadia-shares-hit-media-doubts-parkinsons-drug/

Search